Journal of Postgraduate Medicine, Education and Research

Register      Login

VOLUME 56 , ISSUE 2 ( April-June, 2022 ) > List of Articles

Original Article

Vascular Endothelial Growth Factor as a Marker of Tissue Healing Response in Mangled Extremity: Preliminary Data from an Observational Study

Vishal Kumar, Rajendra K Kanojia, Rohit Kansal, Kim Vaiphei, Mandeep S Dhillon

Keywords : Amputation, Hematoxylin and eosin, Immunohistochemistry, Mangled extremity, Mangled extremity severity score, Vascular endothelial growth factor

Citation Information : Kumar V, Kanojia RK, Kansal R, Vaiphei K, Dhillon MS. Vascular Endothelial Growth Factor as a Marker of Tissue Healing Response in Mangled Extremity: Preliminary Data from an Observational Study. J Postgrad Med Edu Res 2022; 56 (2):81-84.

DOI: 10.5005/jp-journals-10028-1408

License: CC BY-NC 4.0

Published Online: 07-06-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Abstract

Purpose: The postoperative complication rate in mangled extremities is substantially high, irrespective of the nature of surgery performed. We attempted to identify the role of tissue vascular endothelial growth factor (VEGF) as a marker of neovascularization in skeletal muscle postinjury and its prognostic significance if any. Materials and methods: A pilot study, including 30 patients, was conducted at an advanced trauma center in PGIMER, Chandigarh in 2016. Patients were divided into 2 groups, based on the mangled extremity severity score, each containing 15 patients. Group I patients with a score of ≥7 were planned for amputation, whereas group II patients with a score of <7 were planned for limb salvage. Intra-op, skeletal muscle biopsies were taken in group I patients from three different zones. Zone A was the mangled zone; zone C was the clinically healthy zone, and zone B was the intermediate zone. Whereas, in group II, muscle samples were taken pre- and post-debridement. All the skeletal muscle samples were subjected to hematoxylin and eosin (H&E) stain followed by immunohistochemistry (IHC) examination with VEGF antibody in an attempt to identify viable muscle in various areas of the limb. Results: On H&E stained samples, in group I patients, the percentage of viable muscle fibers increases from 6.7 to 73% from zone A to zone C, whereas it increases from 7 to 80% in group II. On IHC stained samples, the median score was 0 (showed no positive staining) in all three zones of group I with a p value >0.05; whereas in group II, the median IHC score was 0 and 1 in pre- and post-debridement samples, respectively, with a p value of 0.004. Conclusion: The higher IHC scores in zone C in group I and post-debridement samples in group II, represent increased VEGF expression in these zones postinjury. This definite increase in VEGF expression, in turn, represents higher neovascularization activity in these zones as a response of the body to repair the damage postinjury.


PDF Share
  1. Prasarn ML, Helfet DL, Kloen P. Management of the mangled extremity. Strategies in Trauma and Limb Reconstruction 2012;1:1–10. DOI: 10.1007/s11751-012-0137-4
  2. Ngim NE, Udosen AM, Ikpene IA, et al. Prospective study of limb injuries in Calabar. Internet J Orthop Surg 2008;8.
  3. Lerner A, Fodor L, Soudry M. Is staged external fixation a valuable strategy for war injuries to the limbs? Clin Orthop Relat Res 2006;448:217–224. DOI: 10.1097/01.blo.0000214411.60722.f8.
  4. Kansal R, Kanojia RK, Kumar V, et al. Role of PAX-7 as a tissue marker in mangled extremity: a pilot study. Eur J Orthop Surg Traumatol 2019;29(5):1131–1140. DOI: 10.1007/s00590-019-02410-w.
  5. Kumar V, Kansal R, Kanojia R, et al. Can we use creatine kinase muscle type as a potential marker for muscle viability in mangled extremities? A preliminary evaluation of its applicability and a literature review. J Musculoskelet Surg Res 2019;3(3):254–259. DOI: 10.4103/jmsr.jmsr_41_19.
  6. Nauta TD, van Hinsbergh VW, Koolwijk P. Hypoxic signaling during tissue repair and regenerative medicine. Int J Mol Sci 2014;15(11):19791–19815. DOI: 10.3390/ijms151119791.
  7. Dvorak HF, Brown LF, Detmar M, et al. Vascular permeability factor/vascular endothelial growth factor, microvascularhyperpermeability, and angiogenesis. Am J Pathol 1995;146:1029–1039.
  8. Holmes K, Roberts OL, Thomas AM, et al. Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition. Cell Signal 2007;19 (10):2003–2012. DOI: 10.1016/j.cellsig.2007.05.013.
  9. Grad S, Ertel W, Keel M, et al. Strongly enhanced serum levels of vascular endothelial growth factor (VEGF) after poly-trauma and burn. Clin Chem Laborat Med 1998;36(6):379–383.
  10. Harker J. Wound healing complications associated with lower limb amputation. World Wide Wounds 2006;9.
  11. Campbell B, Chuhran C, Lefer AM. Vascular endothelial growth factor attenuates trauma-induced injury in rats. Br J Pharmacol 2000;129(1):71–76. DOI: 10.1038/sj.bjp.0703010.
  12. Johnson KE, Wilgus TA. Vascular endothelial growth factor and angiogenesis in the regulation of cutaneous wound repair. Adv Wound Care 2014;3(10):647–661. DOI: 10.1089/wound.2013.0517
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.